Published Date:2022-12-06 Original Link:https://www.onenessbio.com/en/news_detail189_1.htm No 1 Date of announcement 2022/12/06 Time of announcement 17:07:51 Subject Oneness has been invited for a poster presentation with on-site Q&A for the Phase 3 MRCT post-hoc analysis of the DFU new drug, Fespixon at IDF Congress 2022. To which item it meets paragraph 12 Date of events 2022/12/07 Statement...Read More